eli lilly retatrutide press release 2024 2025 Clinical trials show promising results for new weight loss drug: Lilly's Orforglipron, Retatrutide Named as

One year after starting semaglutide, 37.4% of patients taking the drug for obesity lost 10% or more of their body weight, while only 16.6% of those taking it for Type 2 diabetes lost this much weight

40 LingY.-H.ChenS.-P.FannC

Constipation may respond to increased fiber intake, adequate hydration, and physical activity, with stool softeners or gentle laxatives if needed

K., Yamada, K., Chiku, T., Koutmos, M

Cycling off and monitoring response is a smart strategy before reintroducing the compound again

Aluminum induced oxidative stress was directly proportionate with lipid peroxidation having higher concentration of O 2 and H 2 O 2